|
About the Frequently Asked Questions category
|
|
0
|
176
|
8 March 2021
|
|
Beta values in study colocalisation table of study locus page
|
|
2
|
46
|
17 November 2022
|
|
Conserved regions variants
|
|
2
|
73
|
27 July 2022
|
|
What happened to the batch search functionality?
|
|
12
|
738
|
18 July 2022
|
|
How can I view diseases and phenotypes associated with a given target?
|
|
0
|
196
|
8 March 2021
|
|
Exact relationships between drug scores and clinical trial evidence
|
|
7
|
183
|
24 May 2022
|
|
Which version of GTEx does Open Targets Genetics use for colocalization analysis?
|
|
1
|
123
|
20 May 2022
|
|
How does the Platform display direct and indirect evidence?
|
|
7
|
290
|
13 May 2022
|
|
How was LD clumping performed to select eQTLs for candidate gene?
|
|
3
|
118
|
11 May 2022
|
|
What is the best way to query pheWAS traits for multiple variants?
|
|
3
|
142
|
2 May 2022
|
|
Where to find eQTL information regarding a SNP in Open Targets Genetics?
|
|
1
|
107
|
21 March 2022
|
|
Defintion of the fields in the ftp files? Where are the PCHi-C files?
|
|
2
|
133
|
16 March 2022
|
|
Empty results pages
|
|
6
|
113
|
10 March 2022
|
|
Comparing targets in the Open Targets Platform
|
|
1
|
118
|
2 March 2022
|
|
How are rsIDs mapped to unique variants in the Open Targets Genetics portal?
|
|
1
|
108
|
1 March 2022
|
|
Why does the Open Targets Genetics portal display partial L2G scores on Locus pages when there is no evidence of colocalization?
|
|
0
|
143
|
3 November 2021
|
|
Why are beta and odds ratios not always displayed in the Open Targets Genetics Portal?
|
|
0
|
145
|
26 August 2021
|
|
In the “tag variants” section of variant summary pages in the Open Targets Genetics Portal, why do some SNPs have a posterior probability and others don’t?
|
|
0
|
95
|
23 August 2021
|
|
How can I download data from the Open Targets Genetics Portal?
|
|
0
|
408
|
4 August 2021
|
|
How often is the Open Targets Genetics portal updated?
|
|
0
|
126
|
29 July 2021
|
|
In the Open Targets Genetics Portal, what is the “credible set overlap”?
|
|
0
|
201
|
22 July 2021
|
|
How to interpret Variant-to-Gene (V2G) and Locus-to-Gene (L2G) scores in the Open Targets Genetics Portal
|
|
0
|
184
|
19 July 2021
|
|
What fine-mapping and colocalisation software does the Open Targets Genetics Portal use?
|
|
0
|
142
|
14 July 2021
|
|
How are tag variants identified in the Open Targets Genetics Portal?
|
|
0
|
140
|
12 July 2021
|
|
How are UK Biobank study traits identified in the Genetics Portal?
|
|
0
|
169
|
7 July 2021
|
|
What is the difference between the Open Targets Platform and the Open Targets Genetics Portal?
|
|
0
|
158
|
16 June 2021
|
|
Score values from Disease->Target vs. Target->Disease
|
|
3
|
223
|
25 June 2021
|
|
Why doesn't the Platform distinguish between diseases and phenotypes?
|
|
0
|
169
|
6 May 2021
|
|
What ontology is used for disease and phenotype terms?
|
|
0
|
189
|
8 March 2021
|